1901 - 1925 of 6078 Results
Title
Year
-
OPENTitle: Undetected ophthalmological disorders in Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 7Start Page: 3821End Page: 3832Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-022-11014-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-022-11014-0.pdfCitation Count: 16
-
OPENTitle: Low dose DMSO treatment induces oligomerization and accelerates aggregation of α-synucleinJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-07706-2Best OA location URL: https://www.nature.com/articles/s41598-022-07706-2.pdfCitation Count: 13
-
OPENTitle: Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegenerationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2121609119Best OA location URL: https://doi.org/10.1073/pnas.2121609119Citation Count: 37
-
OPENTitle: Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK PopulationJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 4Start Page: 359End Page: 359Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.0003Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2789505/jamaneurology_simonet_2022_oi_220001_1649435706.38428.pdfCitation Count: 54
-
OPENTitle: Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System AtrophyJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 5Start Page: 906End Page: 906Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11050906Best OA location URL: https://www.mdpi.com/2073-4409/11/5/906/pdf?version=1646555264Citation Count: 27
-
OPENTitle: Unique Astrocyte Cytoskeletal and Nuclear Morphology in a Three-Dimensional Tissue-Engineered Rostral Migratory StreamJournal Name: NeurogliaPublisher: MDPI AGVol: 3Issue #: 1Start Page: 41End Page: 60Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/neuroglia3010003Best OA location URL: https://www.mdpi.com/2571-6980/3/1/3/pdf?version=1646557010Citation Count: 4
-
OPENTitle: Long-Term Persistence and Monotherapy with Device-Aided Therapies: A Retrospective Analysis of an Israeli Cohort of Patients with Advanced Parkinson’s DiseaseJournal Name: Advances in TherapyPublisher: Springer Science and Business Media LLCVol: 39Issue #: 5Start Page: 2009End Page: 2024Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s12325-022-02072-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s12325-022-02072-x.pdfCitation Count: 4
-
OPENTitle: A Novel Tissue Atlas and Online Tool for the Interrogation of Small RNA Expression in Human Tissues and BiofluidsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2022.804164Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcell.2022.804164/pdfCitation Count: 13
-
OPENTitle: Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencingJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.abm5386Best OA location URL: https://discovery.ucl.ac.uk/10144893/1/sciadv.abm5386.pdfCitation Count: 130
-
OPENTitle: Overcoming congressional inertia on obesity requires better literacy in obesity scienceJournal Name: ObesityPublisher: WileyVol: 30Issue #: 4Start Page: 799End Page: 801Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/oby.23405Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957554Citation Count: 8
-
OPENTitle: Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain InjuryJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2022.813387Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2022.813387/pdfCitation Count: 28
-
OPENTitle: Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriersJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00285-zBest OA location URL: https://www.nature.com/articles/s41531-022-00285-z.pdfCitation Count: 8
-
OPENTitle: Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort studyJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: 6Start Page: 1685End Page: 1696Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ene.15307Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15307Citation Count: 96
-
OPENTitle: SNCA rs3910105 Is Associated With Development of Rapid Eye Movement Sleep Behavior Disorder in Parkinson’s DiseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.832550Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.832550/pdfCitation Count: 2
-
OPENTitle: The silver linings of Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00283-1Best OA location URL: https://www.nature.com/articles/s41531-022-00283-1.pdfCitation Count: 5
-
OPENTitle: Coffee, smoking and aspirin are associated with age at onset in idiopathic Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 8Start Page: 4195End Page: 4203Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-022-11041-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-022-11041-x.pdfCitation Count: 30
-
OPENTitle: Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 97Issue #:Start Page: 47End Page: 51Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.02.017Best OA location URL: http://www.prd-journal.com/article/S1353802022000505/pdfCitation Count: 7
-
OPENTitle: Current Status of Next-Generation Sequencing Approaches for Candidate Gene Discovery in Familial Parkinson´s DiseaseJournal Name: Frontiers in GeneticsPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fgene.2022.781816Best OA location URL: https://www.frontiersin.org/articles/10.3389/fgene.2022.781816/pdfCitation Count: 9
-
OPENTitle: Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson’s diseaseJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 60Issue #:Start Page: 102733End Page: 102733Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2022.102733Best OA location URL: https://doi.org/10.1016/j.scr.2022.102733Citation Count: 5
-
OPENTitle: More of less: Novel multi-ome profiling of single human neuronsJournal Name: Cell GenomicsPublisher: Elsevier BVVol: 2Issue #: 3Start Page: 100110End Page: 100110Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.xgen.2022.100110Best OA location URL: https://doi.org/10.1016/j.xgen.2022.100110Citation Count: 0
- Targeted Metabolomic Analysis in Alzheimer’s Disease Plasma and Brain Tissue in Non-Hispanic Whites2022OPENTitle: Targeted Metabolomic Analysis in Alzheimer’s Disease Plasma and Brain Tissue in Non-Hispanic WhitesJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 86Issue #: 4Start Page: 1875End Page: 1895Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jad-215448Best OA location URL: https://content.iospress.com:443/download/journal-of-alzheimers-disease/jad215448?id=journal-of-alzheimers-disease%2Fjad215448Citation Count: 39
-
OPENTitle: NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome ActivationJournal Name: International Journal of InflammationPublisher: WileyVol: 2022Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2022/2337363Best OA location URL: https://downloads.hindawi.com/journals/iji/2022/2337363.pdfCitation Count: 5
-
OPENTitle: A Randomized, Double‐Blind, Controlled Phase II Study of Foliglurax in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1088End Page: 1093Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28970Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28970Citation Count: 28
-
OPENTitle: Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-Duration Deep Brain StimulationJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 26Issue #: 2Start Page: 364End Page: 373Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.015Citation Count: 4
-
OPENTitle: CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative BiomarkersJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.834580Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.834580/pdfCitation Count: 24